Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117454) titled 'A Randomized Controlled Trial on the Effectiveness and Safety of Ciliary Body Cryotherapy and Combined Anti-VEGF Therapy for Advanced Neovascular Glaucoma' on Jan. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai First People's Hospital
Condition:
neovascular glaucoma
Intervention:
Experimental group:Cyclocryotherapy combined with anti-VEGF therapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Experimental group:30;Control group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.or...